Source:http://linkedlifedata.com/resource/pubmed/id/16921384
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7109
|
pubmed:dateCreated |
2006-9-21
|
pubmed:abstractText |
Functional impairment of T cells is characteristic of many chronic mouse and human viral infections. The inhibitory receptor programmed death 1 (PD-1; also known as PDCD1), a negative regulator of activated T cells, is markedly upregulated on the surface of exhausted virus-specific CD8 T cells in mice. Blockade of this pathway using antibodies against the PD ligand 1 (PD-L1, also known as CD274) restores CD8 T-cell function and reduces viral load. To investigate the role of PD-1 in a chronic human viral infection, we examined PD-1 expression on human immunodeficiency virus (HIV)-specific CD8 T cells in 71 clade-C-infected people who were naive to anti-HIV treatments, using ten major histocompatibility complex (MHC) class I tetramers specific for frequently targeted epitopes. Here we report that PD-1 is significantly upregulated on these cells, and expression correlates with impaired HIV-specific CD8 T-cell function as well as predictors of disease progression: positively with plasma viral load and inversely with CD4 T-cell count. PD-1 expression on CD4 T cells likewise showed a positive correlation with viral load and an inverse correlation with CD4 T-cell count, and blockade of the pathway augmented HIV-specific CD4 and CD8 T-cell function. These data indicate that the immunoregulatory PD-1/PD-L1 pathway is operative during a persistent viral infection in humans, and define a reversible defect in HIV-specific T-cell function. Moreover, this pathway of reversible T-cell impairment provides a potential target for enhancing the function of exhausted T cells in chronic HIV infection.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/PDCD1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Programmed Cell Death 1 Receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1476-4687
|
pubmed:author |
pubmed-author:AhmedRafiR,
pubmed-author:AltfeldMarcusM,
pubmed-author:BrownJulia AJA,
pubmed-author:CoovadiaHoosen MHM,
pubmed-author:DayCheryl LCL,
pubmed-author:DePierresChantalC,
pubmed-author:DuraiswamyJaikumarJ,
pubmed-author:EichbaumQuentinQ,
pubmed-author:FreemanGordon JGJ,
pubmed-author:GoulderPhilip J RPJ,
pubmed-author:KaufmannDaniel EDE,
pubmed-author:KiepielaPhotiniP,
pubmed-author:KlenermanPaulP,
pubmed-author:LeslieAlasdair JAJ,
pubmed-author:MackeyElizabeth WEW,
pubmed-author:MillerJoseph DJD,
pubmed-author:MncubeZeneleZ,
pubmed-author:MoodleyEshia SES,
pubmed-author:ReddySharonS,
pubmed-author:WalkerBruce DBD,
pubmed-author:WherryE JohnEJ,
pubmed-author:ZhuBaogongB
|
pubmed:issnType |
Electronic
|
pubmed:day |
21
|
pubmed:volume |
443
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
350-4
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16921384-Antigens, CD,
pubmed-meshheading:16921384-Apoptosis Regulatory Proteins,
pubmed-meshheading:16921384-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16921384-CD8-Positive T-Lymphocytes,
pubmed-meshheading:16921384-Disease Progression,
pubmed-meshheading:16921384-Gene Expression,
pubmed-meshheading:16921384-HIV,
pubmed-meshheading:16921384-HIV Infections,
pubmed-meshheading:16921384-Histocompatibility Antigens Class I,
pubmed-meshheading:16921384-Humans,
pubmed-meshheading:16921384-Interferon-gamma,
pubmed-meshheading:16921384-Programmed Cell Death 1 Receptor,
pubmed-meshheading:16921384-Up-Regulation
|
pubmed:year |
2006
|
pubmed:articleTitle |
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
|
pubmed:affiliation |
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu Natal, Durban 4013, South Africa.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|